Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Boot

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2008
Long-term results of stomach-conserving therapy in gastric MALT lymphomaConny Vrieling, Daphne de Jong, Henk Boot, et al.
Leukemia & Lymphoma|August 19, 2011
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironmentJan-Paul de Boer, Markus Raderer, Harm van Tinteren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Jasper Nijkamp, Harm van Tinteren, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?Edwin P M Jansen, Henk Boot, Cornelis J H van de Velde, et al.
Gastrointestinal Endoscopy|June 26, 2012
Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trialNicole C M van Heel, Jelle Haringsma, Henk Boot, et al.
Haematologica|January 29, 2008
Dissemination patterns in non-gastric MALT lymphomaJan Paul de Boer, Reinier Frederik Hiddink, Markus Raderer, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2015
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junctionMaarten J Deenen, Didier Meulendijks, Henk Boot, et al.
Oncology Letters|September 12, 2012
Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancerHelgi H Helgason, Judith Y M N Engwegen, Mark Zapatka, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancerEdwin P M Jansen, Henk Boot, Mark P Saunders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2015
Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Karolina Sikorska, Johanna W van Sandick, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2008
Long-term results of stomach-conserving therapy in gastric MALT lymphomaConny Vrieling, Daphne de Jong, Henk Boot, et al.
Leukemia & Lymphoma|August 19, 2011
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironmentJan-Paul de Boer, Markus Raderer, Harm van Tinteren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Jasper Nijkamp, Harm van Tinteren, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?Edwin P M Jansen, Henk Boot, Cornelis J H van de Velde, et al.
Gastrointestinal Endoscopy|June 26, 2012
Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trialNicole C M van Heel, Jelle Haringsma, Henk Boot, et al.
Haematologica|January 29, 2008
Dissemination patterns in non-gastric MALT lymphomaJan Paul de Boer, Reinier Frederik Hiddink, Markus Raderer, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2015
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junctionMaarten J Deenen, Didier Meulendijks, Henk Boot, et al.
Oncology Letters|September 12, 2012
Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancerHelgi H Helgason, Judith Y M N Engwegen, Mark Zapatka, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancerEdwin P M Jansen, Henk Boot, Mark P Saunders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2015
Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Karolina Sikorska, Johanna W van Sandick, et al.
Pageof 6